Human immunodeficiency virus (HIV) II infection category B1
|
0.010 |
Biomarker
|
disease |
BEFREE |
This article details evidence for productive low-level infection of HCN-1A cells with human immunodeficiency virus type 1 (HIV-1).
|
8318271 |
1993 |
Neoplasm Metastasis
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
Several of the identified genes (eIF4A1, thymosin beta4 and a novel transcript named MALAT-1) were demonstrated to be significantly associated with metastasis in NSCLC patients (n=70).
|
12970751 |
2003 |
Malignant Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The identification of MALAT-1 emphasizes the potential role of noncoding RNAs in human cancer.
|
12970751 |
2003 |
Non-Small Cell Lung Carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Several of the identified genes (eIF4A1, thymosin beta4 and a novel transcript named MALAT-1) were demonstrated to be significantly associated with metastasis in NSCLC patients (n=70).
|
12970751 |
2003 |
Primary malignant neoplasm
|
0.100 |
Biomarker
|
group |
BEFREE |
The identification of MALAT-1 emphasizes the potential role of noncoding RNAs in human cancer.
|
12970751 |
2003 |
stage, non-small cell lung cancer
|
0.030 |
Biomarker
|
disease |
BEFREE |
MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer.
|
12970751 |
2003 |
Non-small cell lung cancer stage I
|
0.010 |
Biomarker
|
disease |
BEFREE |
The Kaplan-Meier analyses identified MALAT-1 and thymosin beta4 as prognostic parameters for patient survival in stage I NSCLC.
|
12970751 |
2003 |
Non-small cell lung cancer stage II
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In our own work, we have identified several genes (e.g. thymosin beta-4, elF4A1), including a novel non-coding RNA (MALAT-1) to be expressed at significantly higher levels in stage-I and stage-II NSCLC primary tumours that subsequently metastasised.
|
15552795 |
2004 |
Tuberculosis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
While high-copy-number IS6110-based restriction fragment length polymorphism (HCN-RFLP) is the gold standard for typing most Mycobacterium tuberculosis strains, the time taken for culturing and low throughput make it impractical for large-scale prospective typing of large numbers of isolates.
|
16825370 |
2006 |
Endometrial Stromal Sarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
All ESS (4/4) and all cases of endometrial stromal cells in the proliferative phase (13/13) were positive for MALAT-1, but samples of normal stroma in the secretory phase and menopausal state included some that were negative or weakly positive for MALAT-1 (5/13 and 3/10, respectively).
|
16441420 |
2006 |
Endometrial Stromal Sarcoma
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
All ESS (4/4) and all cases of endometrial stromal cells in the proliferative phase (13/13) were positive for MALAT-1, but samples of normal stroma in the secretory phase and menopausal state included some that were negative or weakly positive for MALAT-1 (5/13 and 3/10, respectively).
|
16441420 |
2006 |
Carcinoma
|
0.100 |
GeneticVariation
|
group |
BEFREE |
MALAT1 is rearranged in renal tumors harboring the t(6;11)(p21;q13) translocation, and noncoding MALAT1 transcripts are overexpressed in a number of human carcinomas.
|
17311249 |
2007 |
Kidney Neoplasm
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
MALAT1 is rearranged in renal tumors harboring the t(6;11)(p21;q13) translocation, and noncoding MALAT1 transcripts are overexpressed in a number of human carcinomas.
|
17311249 |
2007 |
Heart failure
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
HCN upregulation likely contributes to increased I(f) and may play a role in ventricular and atrial arrhythmogenesis in heart failure.
|
18556018 |
2008 |
Congestive heart failure
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
HCN upregulation likely contributes to increased I(f) and may play a role in ventricular and atrial arrhythmogenesis in heart failure.
|
18556018 |
2008 |
Malignant neoplasm of breast
|
0.400 |
Biomarker
|
disease |
BEFREE |
We also explored the non-protein-coding portion of the breast cancer transcriptome, identifying thousands of novel non-coding transcripts and more than three hundred reads corresponding to the non-coding RNA MALAT1, which is highly expressed in many human carcinomas.
|
19379481 |
2009 |
Breast Carcinoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
We also explored the non-protein-coding portion of the breast cancer transcriptome, identifying thousands of novel non-coding transcripts and more than three hundred reads corresponding to the non-coding RNA MALAT1, which is highly expressed in many human carcinomas.
|
19379481 |
2009 |
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We also explored the non-protein-coding portion of the breast cancer transcriptome, identifying thousands of novel non-coding transcripts and more than three hundred reads corresponding to the non-coding RNA MALAT1, which is highly expressed in many human carcinomas.
|
19379481 |
2009 |
Tumor Cell Invasion
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Metastasis associated lung adenocarcinoma transcript 1 is up-regulated in placenta previa increta/percreta and strongly associated with trophoblast-like cell invasion in vitro.
|
19690017 |
2009 |
Choriocarcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
To investigate the role of MALAT-1 gene in the regulation of trophoblast cell invasion, targeting of MALAT-1 mRNA expression with short interfering RNA (siRNA) in trophoblast-like BeWo, JAR and JEG-3 choriocarcinoma cells was performed.
|
19690017 |
2009 |
Neoplasm Metastasis
|
0.400 |
Biomarker
|
phenotype |
BEFREE |
MALAT-1, a long non-coding RNA, is associated with metastasis, but its role in the metastatic process remains unknown.
|
20937273 |
2010 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
A noncoding RNA, metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), is upregulated in several malignant tumors.
|
20149803 |
2010 |
Carcinoma
|
0.100 |
AlteredExpression
|
group |
BEFREE |
MALAT1 is overexpressed in many human carcinomas, but its function remains unknown.
|
20213048 |
2010 |
Malignant tumor of cervix
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our findings illustrate the biological significance of MALAT1 in cervical cancer progression and provide novel evidence that MALAT1 may serve as a therapeutic target in the prevention of human cervical cancer.
|
20213048 |
2010 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The expression of the tumor marker MALAT1 ncRNA is sensitive to cell surface receptor activation by oxytocin in a neuroblastoma cell line.
|
20149803 |
2010 |